Congenital cytomegalovirus disease — 20 years is long enough

New England Journal of Medicine

Volumn 326, Issue 10, 1992, Pages 702-703

  Yow, Martha D ^a   Demmler, Gail J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS VACCINE; VIRUS GLYCOPROTEIN;

CHILD; COST BENEFIT ANALYSIS; CYTOMEGALOVIRUS INFECTION; EDITORIAL; FAMILY COUNSELING; FEMALE; HUMAN; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SEROLOGY; VACCINE PRODUCTION; VIRUS TRANSMISSION;

EID: 0026584884     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199203053261010     Document Type: Editorial

References (10)

1. Weller T.H. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. N Engl J Med 1971; 285:203-14, 267-74.
2. Dobbins J.G., Stewart J.A., Demmler D.J. Surveillance of congenital cytomegalovirus disease 1991. MMWR (in press).
3. Fowler K.B., Stagno S., Pass R.F., Britt W.J., Boll T.J., Alford C.A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326:663-667
4. Plotkin S.A., Starr S.E., Friedman H.M., Gonczol E., Brayman K. Vaccines for the prevention of human cytomegalovirus infection. Rev Infect Dis 1990; 12:Suppl 7:S827-S838.
5. Spector D.H., Spector S.A. The oncogenic potential of human cytomegalovirus. Prog Med Virol 1984; 29:45-89.
6. Britt W.J., Vugler L., Butfiloski E.J., Stephens E.B. Cell surface expression of human cytomegalovirus (HCMV) gp55–116(gB): use of HCMV-recombinant vaccinia virus–infected cells in analysis of the human neutralizing antibody response. J Virol 1990; 64:1079-1085
7. Marshall G.S., Ricciardi R.P., Rando R.F., et al. An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies. J Infect Dis 1990; 162:1177-1181
8. Porath A., McNutt R.A., Smiley L.M., Weigle K.A. Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease. Rev Infect Dis 1990; 12:31-40.
9. Adler S.P. Cytomegalovirus and child day care: evidence for an increased infection rate among day-care workers. N Engl J Med 1989; 321:1290-1296
10. Demmler G.J. Infectious Diseases Society of America and Centers for Disease Control: summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991; 13:315-329